Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Therapy01:28

Drug Therapy

424
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
424
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
1.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

403
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
403
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

947
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
947
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

2.6K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time trends in strategies for postoperative Crohn's disease management and long-term surgical recurrence: ENEIDA registry data.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Real-World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA Registry.

Alimentary pharmacology & therapeutics·2026
Same author

The Telemonitorización de la Enfermedad de Crohn y Colitis Ulcerosa (Telemonitoring of Crohn's Disease and Ulcerative Colitis)-Based Telemonitoring Platform for Inflammatory Bowel Disease Is Cost-Effective: A Multicenter Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa Trial.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Hidradenitis suppurativa in patients with inflammatory bowel disease: a national multicenter study from the GETECCU-ENEIDA Registry.

Therapeutic advances in gastroenterology·2026
Same author

Biological therapies for inflammatory pouch disorders: insights and outcomes from the RESERVO study of GETECCU.

Therapeutic advances in gastroenterology·2026
Same author

Cytokine Dynamics During Ustekinumab Induction as Predictors of Treatment Response in Crohn's Disease: An Observational Study.

Biomedicines·2025

Related Experiment Video

Updated: Apr 20, 2026

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

14.1K

[Treatment adherence: a key element].

Guillermo Bastida1, Cristina Sánchez Montes2, Mariam Aguas2

  • 1Servicio de Medicina Digestiva, Hospital Universitari i Politecnic La Fe, Valencia, España. guille.bastida@gmail.com

Gastroenterologia Y Hepatologia
|December 3, 2014
PubMed
Summary

Patient adherence to treatment plans is crucial for managing chronic diseases like ulcerative colitis (UC). Identifying patient barriers and involving them in decision-making are key to improving medication adherence and disease control.

Keywords:
Adhesión al tratamientoColitis ulcerosaEnfermedad inflamatoria intestinalInflammatory bowel diseaseTreatment adherenceUlcerative colitis

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

5.4K

Related Experiment Videos

Last Updated: Apr 20, 2026

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

14.1K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

5.4K

Area of Science:

  • Gastroenterology
  • Pharmacology
  • Health Psychology

Background:

  • Patient non-adherence to medical advice impacts chronic disease management, reducing treatment effectiveness and increasing healthcare costs.
  • Ulcerative colitis (UC) is a chronic condition where poor adherence is linked to inadequate disease control and higher expenses.
  • Adherence is a complex issue influenced by factors like psychosocial elements, the patient-physician relationship, and patient beliefs about medication.

Purpose of the Study:

  • To highlight the significance of patient adherence in chronic disease management, particularly in ulcerative colitis.
  • To emphasize the need for identifying patient-specific barriers to medication adherence.
  • To advocate for patient involvement in decision-making processes to enhance treatment adherence.

Main Methods:

  • Literature review on adherence factors in chronic diseases.
  • Analysis of the impact of non-adherence on ulcerative colitis management.
  • Discussion of strategies to improve adherence, focusing on patient engagement.

Main Results:

  • Non-adherence significantly compromises therapeutic outcomes and increases disease-related costs.
  • A single daily dose of aminosalicylates (5-ASA) is as safe and effective as other regimens but does not inherently improve adherence.
  • Identifying the scope of adherence issues and implementing patient-centered strategies are essential.

Conclusions:

  • Improving patient adherence is critical for effective chronic disease management, especially in ulcerative colitis.
  • Strategies must address the multidimensional nature of non-adherence, including psychosocial factors and patient beliefs.
  • Involving patients in shared decision-making is a vital approach to enhance medication adherence and improve disease control.